Cyclin-dependent kinases 4 and 6 (CDK4/6) play an essential role in cellular proliferation and are often dysregulated in breast cancer (BC), particularly in hormone-receptor (HR)-positive disease (Santamaria and Ortega, 2006; Sherr et al., 2016). This evidence concerns the gene NR4A1 and breast cancer.